Capricor extends PDUFA target date to Nov 22, 2026 for Deramiocel
Capricor received a three-month extension for the FDA review of its Deramiocel BLA to incorporate updated HOPE-3 data, reflecting continued regulatory engagement over a refined ind…
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
Capricor received a three-month extension for the FDA review of its Deramiocel BLA to incorporate updated HOPE-3 data, reflecting continued regulatory engagement over a refined ind…
BioCardia announced the FDA has accepted meeting minutes for the Helix Transendocardial Delivery Catheter, which supports a follow-on De Novo pre-submission to potentially clear th…
Precision BioSciences has dosed the first patient in the Phase 1/2 FUNCTION-DMD trial for DMD, marking a significant clinical development milestone for the company's ARCUS gene-edi…
loanDepot received a NYSE deficiency letter because its Class A common stock averaged less than $1.00 over a 30-day period. The company intends to cure the deficiency by June 2027.
KKR Infrastructure Conglomerate LLC has amended and restated its revolving credit agreement with Mizuho Bank and other lenders. The update includes details regarding original issue…
Toppoint Holdings Inc. announced it has postponed its 2026 annual meeting of stockholders from August 24 to September 8, 2026, to allow additional time for shareholders to review p…
Synergy CHC Corp. announced it failed to file its Q2 2026 10-Q in time, triggering a Nasdaq notification. The company has 60 days to submit a compliance plan to avoid delisting.
Azitra, Inc. has been notified by NYSE American that it has resolved continued listing deficiencies under Sections 1003(a)(ii) and 1003(a)(iii) and will no longer carry the '.BC' i…
The Federal Reserve Board announced its approval of an application by National Westminster Bank Plc. The regulatory decision pertains to the financial institution's request.
Charter Communications has filed an amendment to its charter document. The change will become effective on August 19, 2026. The filing does not currently indicate a material impact…
The Federal Reserve Board has taken enforcement action against SouthPoint Bancshares, Inc., while simultaneously announcing the termination of enforcement actions against Deutsche …
Boothill Sports Wagering & Casino acquired a gambling license from the New Mexico Regulation and Gaming Department.
The FDA raised no objections to Protagenic's plan for testing PT00114 for generalized anxiety disorder, with submission targeted for late 2026. The biotech shares advanced to a 'Cl…
Santander Holdings has agreed to contribute its interest in Webster Virginia to itself, transferring the unit into Santander Bank, National Association for regulatory compliance.
The FDA has issued an accelerated approval for Genglycos (pariglasgene brecaparvovec-opnr), marking the first treatment for adults and children aged 8 years and older with glycogen…
The Federal Open Market Committee's July 28-29, 2026, meeting minutes provide a detailed discussion of the economic outlook and policy considerations.
OSR Health will appeal a delisting notice due to a failure to meet the minimum bid price requirement. Trading suspends on August 26.
The FDA authorized the Aletta, the first standalone robotic device that can draw blood from a patient's arm without operator intervention.
Nextpower Inc. filed a Third Amended and Restated Certificate of Incorporation effective November 12, 2025, increasing authorized shares of Common Stock. The amendment reflects a c…
Trio-Tech’s common stock was approved for listing on the Nasdaq Global Market under ticker symbol TRT, set to begin trading on September 16, 2026. The transition aims to enhance vi…